Pages that link to "Q43577458"
Jump to navigation
Jump to search
The following pages link to SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. (Q43577458):
Displaying 14 items.
- Genetic variation in the HSD17B1 gene and risk of prostate cancer (Q24811147) (← links)
- Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications (Q33672581) (← links)
- Polymorphisms in steroidogenesis genes, sex steroid levels, and high myopia in the Taiwanese population (Q35209201) (← links)
- Genetic polymorphisms and prostate cancer risk (Q35597290) (← links)
- Genetic alterations in prostate cancer (Q35782991) (← links)
- Reliability of statistical associations between genes and disease (Q36221786) (← links)
- SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness. (Q36254416) (← links)
- Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes (Q36758880) (← links)
- Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. (Q37151872) (← links)
- Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. (Q37267225) (← links)
- No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned (Q37294754) (← links)
- The complexity of prostate cancer: genomic alterations and heterogeneity. (Q38058243) (← links)
- Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis (Q43595675) (← links)
- Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis (Q45245187) (← links)